Search for: "MATTER OF B P B P" Results 3361 - 3380 of 5,344
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Feb 2008, 10:00 am
  First, in rearing the specter of federal intrusion on matters of traditionally state concern, the Court fails to acknowledge the fact that even the SEC actions expressly allowed by PSLRA § 104, with which the Court takes no issue, do the same. [read post]
26 Aug 2015, 8:30 pm
 The term appeared in the arbitrator's quotation of Insurance Law § 5103(b)(2). [read post]
16 Feb 2018, 6:00 am by Gabriel Schoenfeld
“[B]y and large,” McCarthy continues, the president “should not” interfere in criminal cases. [read post]
25 Mar 2020, 10:41 am by John Elwood
§ 853(p) is applied to a forfeiture imposed under any statute via 28 U.S.C. [read post]
5 Jan 2017, 11:37 am by Heidi A. Nadel
Mitchell, 15-P-858 (Rule 1:28 Decision) (Jul. 5, 2016) vacated the trial court’s anti-SLAPP fees order and remanded the matter to the trial court to try again. [read post]
5 Jan 2017, 11:37 am by Heidi A. Nadel
Mitchell, 15-P-858 (Rule 1:28 Decision) (Jul. 5, 2016) vacated the trial court’s anti-SLAPP fees order and remanded the matter to the trial court to try again. [read post]
5 Jan 2017, 11:37 am by Heidi A. Nadel
Mitchell, 15-P-858 (Rule 1:28 Decision) (Jul. 5, 2016) vacated the trial court’s anti-SLAPP fees order and remanded the matter to the trial court to try again. [read post]
17 Jan 2019, 7:58 pm by MOTP
Both the subcontract and the sub-subcontract contain identical arbitration provisions: 11.3.3 ARBITRATION If the matter is unresolved after submission of the matter to a mitigation procedure or mediation, a demand for arbitration may be served by either Party. [read post]
23 Apr 2018, 1:20 am by Kevin LaCroix
For instance, plaintiffs alleging false or misleading corporate statements in the context of an initial public offering (“IPO”) almost invariably challenge these same statements under both Section 11 and Section 10(b). [read post]
21 Feb 2014, 8:53 am
 (b) The purpose of patient labeling for human prescription drug products required under this part is to provide information when the FDA determines in writing that it is necessary to patients’ safe and effective use of drug products. [read post]
15 Jan 2012, 3:11 pm by Nicholas J. Wagoner
 Bernstein, Brian Resnick, & Hilary Dengel, Thirty-Seventh Annual Lawrence P. [read post]